ClinicalTrials.gg

Rheumatic Diseases clinical trials

The registry lists 264 studies for Rheumatic Diseases across more than 10 countries. 60 are recruiting or about to start. 92 of them are mainly about Rheumatic Diseases (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-09. Counting its 13 narrower conditions too, such as Arthritis, Rheumatoid: 11,488 studies, 2,002 open.

Get an email when these change. Save the Rheumatic Diseases studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
137
Recruiting
41
Status unknown
35
Terminated
17
Not yet recruiting
16
Active, not recruiting
9

Phase

Phase 2
25
Phase 3
20
Phase 1
15
Phase 4
14
Early Phase 1
1

Where

United States
69
France
25
Turkey
24
Germany
22
Canada
18
Brazil
13

What is being tested here

Drugs under test in Rheumatic Diseases studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

Drug classes tested here Antimetabolites 1 open · Tyrosine kinase inhibitors (TKIs) 1 open · JAK inhibitors 1 open

Coming up

15studies finish main data collection within a year

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest

Who these studies take

Of the 41 Rheumatic Diseases studies recruiting now, 18 (44%) set no upper age limit and 12 (29%) stop at 75 or younger. 7 (17%) take children under 18. 3 (7%) are for women only and 0 (0%) for men only; 11 (27%) take healthy volunteers.

Recruiting studies that take each age, of 41
AgeWomenMen
106 (15%)6 (15%)
1836 (88%)33 (80%)
3035 (85%)32 (78%)
4035 (85%)32 (78%)
5034 (83%)32 (78%)
6533 (80%)33 (80%)
7531 (76%)31 (76%)
8527 (66%)27 (66%)

Across all 264 studies, recruiting or not: 31% stop at 75 or younger and 22% at 65; 16% take children; 4% are for women only and 1% for men only; 20% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Rheumatic Diseases studies take

Of 74 interventional studies with no phase under Rheumatic Diseases, half reached primary completion within 26 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Interventional, no phase26 mo10–46 · 74 studies—26 mo10–46 · 72 studies
Observational55 mo14–… · 36 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 13, 2026.

Studies

Recruiting first, then most recently updated. Showing 50 of 264. Browse all 264 → or search them.